Search

Your search keyword '"Hardt, Stefan E."' showing total 268 results
Start Over Author "Hardt, Stefan E."
268 results on '"Hardt, Stefan E."'

1. Multiparametric Evaluation of Radiomics Features and Dual-Energy CT Iodine Maps for Discrimination and Outcome Prediction of Thymic Masses

Author

Mahmoudi, Scherwin, Gruenewald, Leon D., Eichler, Katrin, Althoff, Friederike C., Martin, Simon S., Bernatz, Simon, Booz, Christian, Yel, Ibrahim, Kinzler, Maximilian N., Ziegengeist, Nicole Suarez, Torgashov, Katerina, Mohammed, Hanin, Geyer, Tobias, Scholtz, Jan-Erik, Hammerstingl, Renate M., Weber, Christophe, Hardt, Stefan E., Sommer, Christof M., Gruber-Rouh, Tatjana, Leistner, David M., Vogl, Thomas J., and Koch, Vitali

Published
2023
Full Text
View/download PDF

2. Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients

Author

Koch, Vitali, Gruenewald, Leon D., Albrecht, Moritz H., Eichler, Katrin, Gruber-Rouh, Tatjana, Yel, Ibrahim, Alizadeh, Leona S., Mahmoudi, Scherwin, Scholtz, Jan-Erik, Martin, Simon S., Lenga, Lukas, Vogl, Thomas J., Nour-Eldin, Nour-Eldin A., Bienenfeld, Florian, Hammerstingl, Renate M., Graf, Christiana, Sommer, Christof M., Hardt, Stefan E., Mazziotti, Silvio, Ascenti, Giorgio, Versace, Giovanni Antonio, D'Angelo, Tommaso, and Booz, Christian

Published
2022
Full Text
View/download PDF

4. Unveiling the diagnostic enigma of D‐dimer testing in cancer patients: Current evidence and areas of application.

Author

Gotta, Jennifer, Gruenewald, Leon D., Eichler, Katrin, Martin, Simon S., Mahmoudi, Scherwin, Booz, Christian, Biciusca, Teodora, Reschke, Philipp, Bernatz, Simon, Pinto Dos Santos, Daniel, Scholtz, Jan‐Erik, Alizadeh, Leona S., Nour‐Eldin, Nour‐Eldin A., Hammerstingl, Renate M., Gruber‐Rouh, Tatjana, Mader, Christoph, Hardt, Stefan E., Sommer, Christof M., Bucolo, Giuseppe, and D'Angelo, Tommaso

Subjects
FIBRIN fragment D, CANCER patients, THROMBOEMBOLISM, PULMONARY embolism, VENOUS thrombosis
Abstract

Background: Cancer is a well‐known risk factor for venous thromboembolism (VTE). A combined strategy of D‐dimer testing and clinical pre‐test probability is usually used to exclude VTE. However, its effectiveness is diminished in cancer patients due to reduced specificity, ultimately leading to a decreased clinical utility. This review article seeks to provide a comprehensive summary of how to interpret D‐dimer testing in cancer patients. Methods: In accordance with PRISMA standards, literature pertaining to the diagnostic and prognostic significance of D‐dimer testing in cancer patients was carefully chosen from reputable sources such as PubMed and the Cochrane databases. Results: D‐dimers have not only a diagnostic value in ruling out VTE but can also serve as an aid for rule‐in if their values exceed 10‐times the upper limit of normal. This threshold allows a diagnosis of VTE in cancer patients with a positive predictive value of more than 80%. Moreover, elevated D‐dimers carry important prognostic information and are associated with VTE reoccurrence. A gradual increase in risk for all‐cause death suggests that VTE is also an indicator of biologically more aggressive cancer types and advanced cancer stages. Considering the lack of standardization for D‐dimer assays, it is essential for clinicians to carefully consider the variations in assay performance and the specific test characteristics of their institution. Conclusions: Standardizing D‐dimer assays and developing modified pretest probability models specifically for cancer patients, along with adjusted cut‐off values for D‐dimer testing, could significantly enhance the accuracy and effectiveness of VTE diagnosis in this population. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

5. Homoarginine in the cardiovascular system: Pathophysiology and recent developments

Author

Koch, Vitali, primary, Gruenewald, Leon D., additional, Gruber‐Rouh, Tatjana, additional, Eichler, Katrin, additional, Leistner, David M., additional, Mahmoudi, Scherwin, additional, Booz, Christian, additional, Bernatz, Simon, additional, D'Angelo, Tommaso, additional, Albrecht, Moritz H., additional, Alizadeh, Leona S., additional, Nour‐Eldin, Nour‐Eldin A., additional, Scholtz, Jan‐Erik, additional, Yel, Ibrahim, additional, Vogl, Thomas J., additional, März, Winfried, additional, Hardt, Stefan E., additional, and Martin, Simon S., additional

Published
2022
Full Text
View/download PDF

6. Cancer patients with venous thromboembolism: Diagnostic and prognostic value of elevated D‐dimers

Author

Koch, Vitali, primary, Martin, Simon S., additional, Gruber‐Rouh, Tatjana, additional, Eichler, Katrin, additional, Mahmoudi, Scherwin, additional, Leistner, David M., additional, Scholtz, Jan‐Erik, additional, Bernatz, Simon, additional, Puntmann, Valentina O., additional, Nagel, Eike, additional, Booz, Christian, additional, D'Angelo, Tommaso, additional, Alizadeh, Leona S., additional, Yel, Ibrahim, additional, Ziegengeist, Nicole S., additional, Torgashov, Katerina, additional, Geyer, Tobias, additional, Hardt, Stefan E., additional, Vogl, Thomas J., additional, Gruenewald, Leon D., additional, and Giannitsis, Evangelos, additional

Published
2022
Full Text
View/download PDF

9. Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling

Author

Lehmann, Lorenz H., Rostosky, Julia S., Buss, Sebastian J., Kreusser, Michael M., Krebs, Jutta, Mier, Walter, Enseleit, Frank, Spiger, Katharina, Hardt, Stefan E., Wieland, Thomas, Haass, Markus, Lüscher, Thomas F., Schneider, Michael D., Parlato, Rosanna, Gröne, Hermann-Josef, Haberkorn, Uwe, Yanagisawa, Masashi, Katus, Hugo A., and Backs, Johannes

Published
2014

10. Homoarginine in the cardiovascular system: Pathophysiology and recent developments.

Author

Koch, Vitali, Gruenewald, Leon D., Gruber‐Rouh, Tatjana, Eichler, Katrin, Leistner, David M., Mahmoudi, Scherwin, Booz, Christian, Bernatz, Simon, D'Angelo, Tommaso, Albrecht, Moritz H., Alizadeh, Leona S., Nour‐Eldin, Nour‐Eldin A., Scholtz, Jan‐Erik, Yel, Ibrahim, Vogl, Thomas J., März, Winfried, Hardt, Stefan E., and Martin, Simon S.

Subjects
PATHOLOGICAL physiology, HEART diseases, CARDIOVASCULAR agents, CARDIOVASCULAR diseases, AMINO acids, CARDIOVASCULAR system
Abstract

Upcoming experimental and epidemiological data have identified the endogenous non‐proteinogenic amino acid L‐homoarginine (L‐hArg) not only as a novel biomarker for cardiovascular disease but also as being directly involved in the pathogenesis of cardiac dysfunction. The association of low L‐hArg levels with adverse cardiovascular events and mortality has proposed the idea of nutritional supplementation to rescue pathways inversely associated with cardiovascular health. Subsequent clinical and experimental studies contributed significantly to our knowledge of potential effects on the cardiorenal axis, acting either as a biomarker or a cardiovascular active agent. In this review article, we provide a comprehensive summary of the L‐hArg metabolism, pathophysiological aspects, and current developments in the field of experimental and clinical evidence in favor of protective cardiovascular effects. Establishing a reliable biomarker to identify patients at high risk to die of cardiovascular disease represents one of the main goals for tackling this disease and providing individual therapeutic guidance. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

11. Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload

Author

Koch, Vitali, primary, Gruenewald, Leon D., additional, Gruber‐Rouh, Tatjana, additional, Martin, Simon, additional, Eichler, Katrin, additional, Booz, Christian, additional, Yel, Ibrahim, additional, Vogl, Thomas J., additional, Buchner, Kristina, additional, Hagenmueller, Marco, additional, März, Winfried, additional, Frey, Norbert, additional, Hardt, Stefan E., additional, and Riffel, Johannes H., additional

Published
2022
Full Text
View/download PDF

13. Lung Opacity and Coronary Artery Calcium Score:A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients

Author

Koch, Vitali, Gruenewald, Leon D., Albrecht, Moritz H., Eichler, Katrin, Gruber-Rouh, Tatjana, Yel, Ibrahim, Alizadeh, Leona S., Mahmoudi, Scherwin, Scholtz, Jan Erik, Martin, Simon S., Lenga, Lukas, Vogl, Thomas J., Nour-Eldin, Nour Eldin A., Bienenfeld, Florian, Hammerstingl, Renate M., Graf, Christiana, Sommer, Christof M., Hardt, Stefan E., Mazziotti, Silvio, Ascenti, Giorgio, Versace, Giovanni Antonio, D'Angelo, Tommaso, Booz, Christian, Koch, Vitali, Gruenewald, Leon D., Albrecht, Moritz H., Eichler, Katrin, Gruber-Rouh, Tatjana, Yel, Ibrahim, Alizadeh, Leona S., Mahmoudi, Scherwin, Scholtz, Jan Erik, Martin, Simon S., Lenga, Lukas, Vogl, Thomas J., Nour-Eldin, Nour Eldin A., Bienenfeld, Florian, Hammerstingl, Renate M., Graf, Christiana, Sommer, Christof M., Hardt, Stefan E., Mazziotti, Silvio, Ascenti, Giorgio, Versace, Giovanni Antonio, D'Angelo, Tommaso, and Booz, Christian

Abstract

Purpose: To assess and correlate pulmonary involvement and outcome of SARS-CoV-2 pneumonia with the degree of coronary plaque burden based on the CAC-DRS classification (Coronary Artery Calcium Data and Reporting System). Methods: This retrospective study included 142 patients with confirmed SARS-CoV-2 pneumonia (58 ± 16 years; 57 women) who underwent non-contrast CT between January 2020 and August 2021 and were followed up for 129 ± 72 days. One experienced blinded radiologist analyzed CT series for the presence and extent of calcified plaque burden according to the visual and quantitative HU-based CAC-DRS Score. Pulmonary involvement was automatically evaluated with a dedicated software prototype by another two experienced radiologists and expressed as Opacity Score. Results: CAC-DRS Scores derived from visual and quantitative image evaluation correlated well with the Opacity Score (r=0.81, 95% CI 0.76-0.86, and r=0.83, 95% CI 0.77-0.89, respectively; p<0.0001) with higher correlation in severe than in mild stage SARS-CoV-2 pneumonia (p<0.0001). Combined, CAC-DRS and Opacity Scores revealed great potential to discriminate fatal outcomes from a mild course of disease (AUC 0.938, 95% CI 0.89-0.97), and the need for intensive care treatment (AUC 0.801, 95% CI 0.77-0.83). Visual and quantitative CAC-DRS Scores provided independent prognostic information on all-cause mortality (p=0.0016 and p<0.0001, respectively), both in univariate and multivariate analysis. Conclusions: Coronary plaque burden is strongly correlated to pulmonary involvement, adverse outcome, and death due to respiratory failure in patients with SARS-CoV-2 pneumonia, offering great potential to identify individuals at high risk.

Published
2022

14. Cancer patients with venous thromboembolism: Diagnostic and prognostic value of elevated D‐dimers.

Author

Koch, Vitali, Martin, Simon S., Gruber‐Rouh, Tatjana, Eichler, Katrin, Mahmoudi, Scherwin, Leistner, David M., Scholtz, Jan‐Erik, Bernatz, Simon, Puntmann, Valentina O., Nagel, Eike, Booz, Christian, D'Angelo, Tommaso, Alizadeh, Leona S., Yel, Ibrahim, Ziegengeist, Nicole S., Torgashov, Katerina, Geyer, Tobias, Hardt, Stefan E., Vogl, Thomas J., and Gruenewald, Leon D.

Subjects
THROMBOEMBOLISM, PROGNOSIS, VENOUS thrombosis, CANCER patients, CANCER-related mortality
Abstract

Background: D‐dimer testing is known to have a high sensitivity at simultaneously low specificity, resulting in nonspecific elevations in a variety of conditions. Methods: This retrospective study sought to assess diagnostic and prognostic features of D‐dimers in cancer patients referred to the emergency department for suspected pulmonary embolism (PE) and deep vein thrombosis (DVT). In total, 526 patients with a final adjudicated diagnosis of PE (n = 83) and DVT (n = 69) were enrolled, whereas 374 patients served as the comparative group, in which venous thromboembolism (VTE) has been excluded. Results: For the identification of VTE, D‐dimers yielded the highest positive predictive value of 96% (95% confidence interval (CI), 85–99) at concentrations of 9.9 mg/L and a negative predictive value of 100% at.6 mg/L (95% CI, 97–100). At the established rule‐out cut‐off level of.5 mg/L, D‐dimers were found to be very sensitive (100%) at a moderate specificity of nearly 65%. Using an optimised cut‐off value of 4.9 mg/L increased the specificity to 95% for the detection of life‐threatening VTE at the cost of moderate sensitivities (64%). During a median follow‐up of 30 months, D‐dimers positively correlated with the reoccurrence of VTE (p =.0299) and mortality in both cancer patients with VTE (p <.0001) and without VTE (p =.0008). Conclusions: Although D‐dimer testing in cancer patients is discouraged by current guidelines, very high concentrations above the 10‐fold upper reference limit contain diagnostic and prognostic information and might be helpful in risk assessment, while low concentrations remain useful for ruling out VTE. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

15. Supplemental Material, sj-docx-3-cpt-10.1177_10742484211054620 - Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

Author

Koch, Vitali, Weber, Christophe, Riffel, Johannes H., Buchner, Kristina, Buss, Sebastian J., Hein, Selina, Mereles, Derliz, Hagenmueller, Marco, Erbel, Christian, M��rz, Winfried, Booz, Christian, Albrecht, Moritz H., Vogl, Thomas J., Frey, Norbert, Hardt, Stefan E., and Ochs, Marco

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, Cardiology, 110323 Surgery, 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, sj-docx-3-cpt-10.1177_10742484211054620 for Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure by Vitali Koch, Christophe Weber, Johannes H. Riffel, Kristina Buchner, Sebastian J. Buss, Selina Hein, Derliz Mereles, Marco Hagenmueller, Christian Erbel, Winfried M��rz, Christian Booz, Moritz H. Albrecht, Thomas J. Vogl, Norbert Frey, Stefan E. Hardt and Marco Ochs in Journal of Cardiovascular Pharmacology and Therapeutics

Published
2022
Full Text
View/download PDF

16. Supplemental Material, sj-docx-1-cpt-10.1177_10742484211054620 - Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

Author

Koch, Vitali, Weber, Christophe, Riffel, Johannes H., Buchner, Kristina, Buss, Sebastian J., Hein, Selina, Mereles, Derliz, Hagenmueller, Marco, Erbel, Christian, M��rz, Winfried, Booz, Christian, Albrecht, Moritz H., Vogl, Thomas J., Frey, Norbert, Hardt, Stefan E., and Ochs, Marco

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, Cardiology, 110323 Surgery, 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, sj-docx-1-cpt-10.1177_10742484211054620 for Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure by Vitali Koch, Christophe Weber, Johannes H. Riffel, Kristina Buchner, Sebastian J. Buss, Selina Hein, Derliz Mereles, Marco Hagenmueller, Christian Erbel, Winfried M��rz, Christian Booz, Moritz H. Albrecht, Thomas J. Vogl, Norbert Frey, Stefan E. Hardt and Marco Ochs in Journal of Cardiovascular Pharmacology and Therapeutics

Published
2022
Full Text
View/download PDF

17. Supplemental Material, sj-docx-2-cpt-10.1177_10742484211054620 - Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

Author

Koch, Vitali, Weber, Christophe, Riffel, Johannes H., Buchner, Kristina, Buss, Sebastian J., Hein, Selina, Mereles, Derliz, Hagenmueller, Marco, Erbel, Christian, M��rz, Winfried, Booz, Christian, Albrecht, Moritz H., Vogl, Thomas J., Frey, Norbert, Hardt, Stefan E., and Ochs, Marco

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, Cardiology, 110323 Surgery, 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, sj-docx-2-cpt-10.1177_10742484211054620 for Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure by Vitali Koch, Christophe Weber, Johannes H. Riffel, Kristina Buchner, Sebastian J. Buss, Selina Hein, Derliz Mereles, Marco Hagenmueller, Christian Erbel, Winfried M��rz, Christian Booz, Moritz H. Albrecht, Thomas J. Vogl, Norbert Frey, Stefan E. Hardt and Marco Ochs in Journal of Cardiovascular Pharmacology and Therapeutics

Published
2022
Full Text
View/download PDF

18. Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

Author

Koch, Vitali, primary, Weber, Christophe, additional, Riffel, Johannes H., additional, Buchner, Kristina, additional, Buss, Sebastian J., additional, Hein, Selina, additional, Mereles, Derliz, additional, Hagenmueller, Marco, additional, Erbel, Christian, additional, März, Winfried, additional, Booz, Christian, additional, Albrecht, Moritz H., additional, Vogl, Thomas J., additional, Frey, Norbert, additional, Hardt, Stefan E., additional, and Ochs, Marco, additional

Published
2022
Full Text
View/download PDF

29. Homoarginine Treatment of Rats Improves Cardiac Function and Remodeling in Response to Pressure Overload

Author

Koch, Vitali, primary, Ochs, Marco, additional, Weber, Christophe, additional, Buchner, Kristina, additional, Mereles, Derliz, additional, Hagenmueller, Marco, additional, Buss, Sebastian J, additional, Hein, Selina, additional, Erbel, Christian, additional, März, Winfried, additional, Frey, Norbert, additional, Hardt, Stefan E, additional, and Riffel, Johannes H, additional

Published
2021
Full Text
View/download PDF

39. Aortic pressure-diameter relationship assessed by intravascular ultrasound: experimental validation in dogs

Author

Hardt, Stefan E., Just, Armin, Bekeredjian, Raffi, Kubler, Wolfgang, Kirchheim, Hartmut R., and Kuecherer, Helmut F.

Subjects
Ultrasonics -- Evaluation, Aorta, Biological sciences
Abstract

Measurements of abdominal aortic diameters derived from intravascular ultrasound (IVUS) and those obtained from sonomicrometers were compared to assess the validity of IVUS in assessing the changes in pressure-diameter relationship. Sonomicrometer measurements were matched by IVUS at different blood pressure levels. The results showed that IVUS is a feasible method in measuring dynamic changes in aortic dimensions and has the potential to provide ready access to assess aortic compliance in humans.

Published
1999

43. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder

Author

Hardt, Stefan E, Eicken, Andreas, Berger, Felix, Schubert, Stephan, Carminati, Mario, Butera, Gianfranco, Grohmann, Jochen, Höhn, Rene, Nielsen-Kudsk, Jens Erik, Hildick-Smith, David, Settergren, Magnus, Thomson, John D, Geis, Nicolas, and Søndergaard, Lars

Subjects
Journal Article
Abstract

AIMS: The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO.METHODS AND RESULTS: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6%) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2% of subjects at discharge evaluation and 96.9% at 6 months follow-up.CONCLUSION: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up. © 2017 Wiley Periodicals, Inc.

Published
2017

44. Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway

Author

Fan, Jingjing, primary, Qiu, Lin, additional, Shu, Hongyang, additional, Ma, Ben, additional, Hagenmueller, Marco, additional, Riffel, Johannes H., additional, Meryer, Soeren, additional, Zhang, Min, additional, Hardt, Stefan E., additional, Wang, Lin, additional, Wang, Dao Wen, additional, Qiu, Hongyu, additional, and Zhou, Ning, additional

Published
2017
Full Text
View/download PDF

45. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder:Results from a prospective European multicenter study

Author

Hardt, Stefan E, Eicken, Andreas, Berger, Felix, Schubert, Stephan, Carminati, Mario, Butera, Gianfranco, Grohmann, Jochen, Höhn, Rene, Nielsen-Kudsk, Jens Erik, Hildick-Smith, David, Settergren, Magnus, Thomson, John D, Geis, Nicolas, Søndergaard, Lars, Hardt, Stefan E, Eicken, Andreas, Berger, Felix, Schubert, Stephan, Carminati, Mario, Butera, Gianfranco, Grohmann, Jochen, Höhn, Rene, Nielsen-Kudsk, Jens Erik, Hildick-Smith, David, Settergren, Magnus, Thomson, John D, Geis, Nicolas, and Søndergaard, Lars

Abstract

AIMS: The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for rapid and effective closure of patent foramen ovale (PFO) which has distinctive features making it suitable for a broad spectrum of anatomical variations. We report the procedural and 6 months follow-up results of the first prospective, multicenter study using GSO.METHODS AND RESULTS: This single-arm study included 150 subjects undergoing closure of PFO in 10 European centers. In 149 out of 150 patients implantation of a GSO device was successful. One patient had a different PFO-closure device implanted. Periprocedural complications were few including one patient with suspected transient ischemic attack, two access site bleedings, and one patient with AV-fistula. No device embolization occurred. During the 6-month follow-up period one patient had a transient asymptomatic thrombus on the device and four patients (2.6%) were diagnosed new onset paroxysmal atrial fibrillation, which were successfully treated. No thrombembolic events occurred. Closure was successful in 94.2% of subjects at discharge evaluation and 96.9% at 6 months follow-up.CONCLUSION: This prospective, multicenter study adds to previous published data and suggests that GSO is a versatile device for PFO closure with high procedural and closure success rates and low complication rates through mid-term follow-up. © 2017 Wiley Periodicals, Inc.

Published
2017

46. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study

Author

Hardt, Stefan E., primary, Eicken, Andreas, additional, Berger, Felix, additional, Schubert, Stephan, additional, Carminati, Mario, additional, Butera, Gianfranco, additional, Grohmann, Jochen, additional, Höhn, Rene, additional, Nielsen-Kudsk, Jens Erik, additional, Hildick-Smith, David, additional, Settergren, Magnus, additional, Thomson, John D., additional, Geis, Nicolas, additional, and Søndergaard, Lars, additional

Published
2017
Full Text
View/download PDF

48. Anterior Aortic Plane Systolic Excursion: A Novel Indicator of Transplant-Free Survival in Systemic Light-Chain Amyloidosis

Author

Ochs, Marco M., Riffel, Johannes, Kristen, Arnt V., Hegenbart, Ute, Schönland, Stefan, Hardt, Stefan E., Katus, Hugo A., Mereles, Derliz, and Buss, Sebastian J.

Abstract

Anterior aortic plane systolic excursion (AAPSE) was evaluated in the present pilot study as a novel echocardiographic indicator of transplant-free survival in patients with systemic light-chain amyloidosis.

Published
2024
Full Text
View/download PDF

49. Cardiac Effects of Attenuating Gsα - Dependent Signaling

Author

Streit, Marcus R., primary, Weiss, Celine S., additional, Meyer, Sören, additional, Ochs, Marco M., additional, Hagenmueller, Marco, additional, Riffel, Johannes H., additional, Buss, Sebastian J., additional, Heger, Thomas, additional, Katus, Hugo A., additional, and Hardt, Stefan E., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results